Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaccines

Showing results (211-220 of 10,021) with videos related to

Pageof 1,003
Sort By:
Vaccines|February 12, 2021
Elderly Subjects Supplemented with L-Glutamine Shows an Improvement of Mucosal Immunity in the Upper Airways in Response to Influenza Virus VaccinationVitória Paixão, Ewin B Almeida, Jonatas B Amaral, et al.
Vaccines|February 12, 2021
Advancements in mRNA Encoded Antibodies for Passive ImmunotherapyCailin E Deal, Andrea Carfi, Obadiah J Plante
Vaccines|March 8, 2017
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue ArchitectureFederico Garrido, Francisco Perea, Mónica Bernal, et al.
Vaccines|January 14, 2021
Efficacy of a Turkey Herpesvirus Vectored Newcastle Disease Vaccine against Genotype VII.1.1 Virus: Challenge Route Affects Shedding PatternVilmos Palya, Tímea Tatár-Kis, Abdel Satar A Arafa, et al.
Vaccines|January 14, 2021
A COVID-19 Vaccine: Big Strides Come with Big ChallengesJuanita Mellet, Michael S Pepper
Vaccines|August 9, 2019
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate MarkersRalf Duerr, Miroslaw K Gorny
Vaccines|April 23, 2025
Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2Jiayang Wang, Qi Qian, Yushan Jiang, et al.
Vaccines|April 23, 2025
Impact of Measles, Mumps, and Rubella Vaccination on Hospitalizations and Human Capital: Evidence from Copenhagen School Health RecordsOnur Altindag, Jane Greve, Erdal Tekin
Vaccines|April 23, 2025
Synthetic rEg.P29 Peptides Induce Protective Immune Responses Against <i>Echinococcus granulosus</i> in MiceYongxue Lv, Jing Tang, Tao Li, et al.
Vaccines|April 23, 2025
Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in SpainAlberto Perez-Rubio, Roberto Flores, Jesus Ruiz Aragon, et al.
Pageof 1,003

Showing results (211-220 of 10,021) with videos related to

Sort By:
Pageof 1,003
Vaccines|February 12, 2021
Elderly Subjects Supplemented with L-Glutamine Shows an Improvement of Mucosal Immunity in the Upper Airways in Response to Influenza Virus VaccinationVitória Paixão, Ewin B Almeida, Jonatas B Amaral, et al.
Vaccines|February 12, 2021
Advancements in mRNA Encoded Antibodies for Passive ImmunotherapyCailin E Deal, Andrea Carfi, Obadiah J Plante
Vaccines|March 8, 2017
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue ArchitectureFederico Garrido, Francisco Perea, Mónica Bernal, et al.
Vaccines|January 14, 2021
Efficacy of a Turkey Herpesvirus Vectored Newcastle Disease Vaccine against Genotype VII.1.1 Virus: Challenge Route Affects Shedding PatternVilmos Palya, Tímea Tatár-Kis, Abdel Satar A Arafa, et al.
Vaccines|January 14, 2021
A COVID-19 Vaccine: Big Strides Come with Big ChallengesJuanita Mellet, Michael S Pepper
Vaccines|August 9, 2019
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate MarkersRalf Duerr, Miroslaw K Gorny
Vaccines|April 23, 2025
Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2Jiayang Wang, Qi Qian, Yushan Jiang, et al.
Vaccines|April 23, 2025
Impact of Measles, Mumps, and Rubella Vaccination on Hospitalizations and Human Capital: Evidence from Copenhagen School Health RecordsOnur Altindag, Jane Greve, Erdal Tekin
Vaccines|April 23, 2025
Synthetic rEg.P29 Peptides Induce Protective Immune Responses Against <i>Echinococcus granulosus</i> in MiceYongxue Lv, Jing Tang, Tao Li, et al.
Vaccines|April 23, 2025
Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in SpainAlberto Perez-Rubio, Roberto Flores, Jesus Ruiz Aragon, et al.
Pageof 1,003